Name | Number of supported studies | Average coverage | |
---|---|---|---|
erythrocyte | 10 studies | 52% ± 15% | |
B cell | 4 studies | 23% ± 7% | |
epithelial cell | 4 studies | 33% ± 10% | |
squamous epithelial cell | 3 studies | 30% ± 20% | |
germinal center B cell | 3 studies | 28% ± 4% | |
macrophage | 3 studies | 21% ± 3% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 29% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2218.37 | 180 / 180 | 100% | 64.22 | 430 / 430 |
stomach | 100% | 1577.58 | 359 / 359 | 100% | 58.35 | 286 / 286 |
esophagus | 100% | 2700.99 | 1444 / 1445 | 100% | 69.29 | 183 / 183 |
lung | 100% | 2406.35 | 577 / 578 | 100% | 72.89 | 1155 / 1155 |
intestine | 100% | 1980.31 | 966 / 966 | 100% | 57.48 | 526 / 527 |
uterus | 100% | 2189.46 | 170 / 170 | 100% | 58.39 | 458 / 459 |
breast | 100% | 2334.62 | 459 / 459 | 100% | 74.00 | 1115 / 1118 |
prostate | 100% | 2194.14 | 245 / 245 | 100% | 52.99 | 500 / 502 |
bladder | 100% | 1930.52 | 21 / 21 | 99% | 52.28 | 499 / 504 |
thymus | 100% | 2287.36 | 653 / 653 | 99% | 37.40 | 597 / 605 |
pancreas | 100% | 1478.30 | 327 / 328 | 99% | 43.61 | 176 / 178 |
brain | 98% | 1138.59 | 2576 / 2642 | 100% | 55.83 | 705 / 705 |
skin | 100% | 2397.20 | 1808 / 1809 | 97% | 42.06 | 456 / 472 |
kidney | 100% | 1836.99 | 89 / 89 | 96% | 33.63 | 864 / 901 |
adrenal gland | 100% | 5359.46 | 258 / 258 | 94% | 31.23 | 217 / 230 |
liver | 100% | 1388.19 | 226 / 226 | 92% | 25.80 | 373 / 406 |
adipose | 100% | 2357.87 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 78.34 | 29 / 29 |
muscle | 100% | 1905.96 | 803 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 8385.10 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 2654.98 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 58.33 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.20 | 1 / 1 |
blood vessel | 100% | 1568.49 | 1329 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 1156.05 | 820 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 91% | 23.79 | 73 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0010506 | Biological process | regulation of autophagy |
GO_0140627 | Biological process | ubiquitin-dependent protein catabolic process via the C-end degron rule pathway |
GO_0042110 | Biological process | T cell activation |
GO_0005813 | Cellular component | centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0080008 | Cellular component | Cul4-RING E3 ubiquitin ligase complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | DCAF12 |
Protein name | DDB1 and CUL4 associated factor 12 DDB1- and CUL4-associated factor 12 (Centrosome-related protein TCC52) (Testis cancer centrosome-related protein) (WD repeat-containing protein 40A) |
Synonyms | WDR40A KIAA1892 TCC52 |
Description | FUNCTION: Substrate-recognition component of a DCX (DDB1-CUL4-X-box) E3 ubiquitin-protein ligase complex of the DesCEND (destruction via C-end degrons) pathway, which recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation . The C-degron recognized by the DesCEND pathway is usually a motif of less than ten residues and can be present in full-length proteins, truncated proteins or proteolytically cleaved forms . The DCX(DCAF12) complex specifically recognizes proteins with a diglutamate (Glu-Glu) at the C-terminus, such as MAGEA3, MAGEA6 and CCT5, leading to their ubiquitination and degradation . Ubiquitination of MAGEA3, MAGEA6 by DCX(DCAF12) complex is required for starvation-induced autophagy . Also directly recognizes the C-terminal glutamate-leucine (Glu-Leu) degron as an alternative degron in proteins such as MOV10, leading to their ubiquitination and degradation. Controls the protein level of MOV10 during spermatogenesis and in T cells, especially after their activation . . |
Accessions | ENST00000361264.9 Q5T6F0 ENST00000396990.6 X6RBJ8 X6RL26 ENST00000450964.1 |